GLP-1 and SGLT-2 Therapies Reshaping Treatment Standards GLP-1 receptor agonists and SGLT-2 inhibitors have become two of the fastest-growing drug classes within the diabetes drugs market
A licensed provider will determine whether compounded semaglutide may be appropriate based on health history, goals, and individual needs
"In order to see the results demonstrated in studies, GLP-1 medications should be combined with dietary and lifestyle interventions," says Samantha Flanagan, DO, an obesity medicine specialist with Temple Health in Philadelphia
doi: 10.3390/nu12082178 Summary Keywords insulin resistance, L-carnitine, lipid metabolism, MASLD, mitochondrial function Citation Chen C, Zou J, Li L, Liu S, Liu Z, Yao L, Peng P, Liang J, Chen Z, Huang H and Huang J (2026) Lcarnitine in metabolic dysfunction-associated steatotic liver disease: mechanisms and therapeutic potential